Characterization of a Live-Attenuated Retroviral Vaccine Demonstrates Protection via Immune Mechanisms
AUTOR(ES)
Dittmer, Ulf
FONTE
American Society for Microbiology
RESUMO
Live-attenuated retroviruses have been shown to be effective retroviral vaccines, but currently little is known regarding the mechanisms of protection. In the present studies, we used Friend virus as a model to analyze characteristics of a live-attenuated vaccine in protection against virus-induced disease. Highly susceptible mice were immunized with nonpathogenic Friend murine leukemia helper virus (F-MuLV), which replicates poorly in adult mice. Further attenuation of the vaccine virus was achieved by crossing the Fv-1 genetic resistance barrier. The minimum dose of vaccine virus required to protect 100% of the mice against challenge with pathogenic Friend virus complex was determined to be 103 focus-forming units of attenuated virus. Live vaccine virus was necessary for induction of immunity, since inactivated F-MuLV did not induce protection. To determine whether immune cells mediated protection, spleen cells from vaccinated donor mice were adoptively transferred into syngeneic recipients. The results indicated that immune mechanisms rather than viral interference mediated protection.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=109828Documentos Relacionados
- Characterization of CHAT and Cox Type 1 Live-Attenuated Poliovirus Vaccine Strains
- Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.
- ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and Efficacy
- Production of Bovine Herpesvirus Type 1-Seronegative Latent Carriers by Administration of a Live-Attenuated Vaccine in Passively Immunized Calves
- Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics
